Zopapogene imadenovec-drba

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Zopapogene Imadenovec for the Treatment of Recurrent Respiratory Papillomatosis in ChildrenNCT07901738PGENPhase 3Not yet recruiting2029-01Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.